References
  1. Moran AE, Holzapfel KL, Xing Y et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med 2011; 208:1279-89.
  2. Jordan MS, Boesteanu A, Reed AJ et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001; 2:301-6.
  3. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005; 6:152-62.
  4. Nazzal D, Gradolatto A, Truffault F et al. Human thymus medullary epithelial cells promote regulatory T-cell generation by stimulating interleukin-2 production via ICOS ligand. Cell Death Dis 2014; 5:e1420.
  5. Watanabe N, Wang YH, Lee HK et al. Hassall’s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005; 436:1181-5.
  6. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-6.
  7. Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73.
  8. Gavin MA, Rasmussen JP, Fontenot JD et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007; 445:771-5.
  9. Lin W, Haribhai D, Relland LM, et al. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 2007; 8:359-68.
  10. Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445:766-70.
  11. Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, Bellucci R, Raderschall E, Canning C, Soiffer RJ, Frank DA, Ritz J. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood. 2006 Sep 1;108(5):1571-9.
  12. Tone Y, Furuuchi K, Kojima Y et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008; 9:194-202.
  13. Burchill MA, Yang J, Vogtenhuber C et al. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 2007; 178:280-90.
  14. Feske S, Müller JM, Graf D et al. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol 1996; 26:2119-26.
  15. Sauer S, Bruno L, Hertweck A et al T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 2008; 105:7797-802.
  16. Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-86.
  17. Horwitz DA, Zheng SG, Wang J, Gray JD. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur J Immunol 2008; 38:912-5.
  18. Semple K, Nguyen A, Yu Y et al. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood 2011; 117:3096-103.
  19. Gottschalk RA, Corse E, Allison JP. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 2010 Aug 2;207(8):1701-11.
  20. Kretschmer K, Apostolou I, Hawiger D et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005; 6:1219-27.
  21. Zeng H, Zhang R, Jin B, Chen L. Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance. Cell Mol Immunol 2015; 12:566-71.
  22. Groux H, O’Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-42.
  23. Gagliani N, Magnani CF, Huber S et al. Co-expression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 2013; 19:739-46.
  24. Jin JO, Han X, Yu Q. Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J Autoimmun 2013; 40:28-44.
  25. Pot C, Jin H, Awasthi A et al. Cutting edge: IL-27 induces the transcription factor c-Maf cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 2009; 183:797-801.
  26. Levings MK, Gregori S, Tresoldi E et al. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 2005; 105:1162-9.
  27. Yang Y, Ochando J, Yopp A et al. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation. J Immunol 2005;174:2720-9.
  28. Wang H, Meng R, Li Z et al. IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3. Immunol Lett 2011; 136:21-8.
  29. Hashemi V, Farrokhi AS, Tanomand A et al. Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population. Immunol Lett 2018; 204:16-22.
  30. Rossetti M, Spreafico R, Consolaro A et al. TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis. Ann Rheum Dis 2017; 76:435-441.
  31. Zare HR, Habibagahi M, Vahdati A, Habibagahi Z. Patients with Active Rheumatoid Arthritis Have Lower Frequency of nTregs in Peripheral Blood. Iran J Immunol 2015; 12:166-75.
  32. Beavis PA, Gregory B, Green P et al. Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic Foxp3 expression in pathogenic synovial T cells. Proc Natl Acad Sci U S A 2011; 108:16717-22.
  33. Haas J, Hug A, Viehöver A et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 2005; 35:3343-52.
  34. Azimi M, Ghabaee M, Moghadasi AN et al. Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis. Immunol Res 2018; 66:513-520.
  35. Kimura K, Hohjoh H, Fukuoka M et al. Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis. Nat Commun 2018; 9:17.
  36. Venken K, Hellings N, Broekmans T et al. Natural naive CD4+CD25+CD127lowregulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J Immunol 2008; 180:6411-20.
  37. Sambucci M, Gargano F, De Rosa V et al. FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis. Sci Rep 2018; 8:3674.
  38. Kato R, Sumitomo S, Tsuchida Y et al. CD4+CD25+LAG3+ T cells with a feature of Th17 cells associated with systemic lupus erythematosus disease activity. Front Immunol 2019; 10:1619.
  39. Jin X, Zhang C, Gong L, Li H, Wang Y, Li Q, Li H. Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients. J Diabetes 2019; 11:440-448.
  40. Scherm MG, Serr I, Zahm AM et al. miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes. Nat Commun 2019; 10:5697.
  41. Hope CM, Welch J, Mohandas A et al. Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes. Eur J Immunol 2019; 49:1235-250.
  42. Kurup SP, Obeng-Adjei N, Anthony SM et al. Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4. Nat Med 2017; 23:1220-225.
  43. Boyle MJ, Jagannathan P, Farrington LA et al. Decline of FoxP3+ Regulatory CD4 T cells in peripheral blood of children heavily exposed to malaria. PLoS Pathog 2015; 11:e1005041.
  44. Tillu H, Tripathy AS, Reshmi PV, Cecilia D. Altered profile of regulatory T cells and associated cytokines in mild and moderate dengue. Eur J Clin Microbiol Infect Dis 2016; 35:453-61.
  45. Jayaratne HE, Wijeratne D, Fernando S et al. Regulatory T-cells in acute dengue viral infection. Immunology 2018; 154:89-97.
  46. Roider J, Ngoepe A, Muenchhoff M, et al. Increased regulatory T-cell activity and enhanced T-cell homeostatic signaling in slow progressing HIV-infected children. Front Immunol. 2019; 10:213.
  47. Eggena MP, Barugahare B, Jones N et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005;174:4407-14.
  48. Chase AJ, Yang HC, Zhang H et al. Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. J Virol 2008; 82: 8307-15.
  49. Xiao J, Zhang L, Dong Y et al. PD-1 Upregulation is associated with exhaustion of regulatory T cells and reflects immune activation in HIV-1-infected individuals. AIDS Res Hum Retroviruses 2019; 35:444-452.
  50. Younes SA, Talla A, Pereira Ribeiro S et al. Cycling CD4+ T cells in HIV-infected immune non-responders have mitochondrial dysfunction. J Clin Invest 2018; 128:5083-94.
  51. Whibley N, Maccallum DM, Vickers MA et al. Expansion of Foxp3+ T-cell populations by Candida albicansenhances both Th17-cell responses and fungal dissemination after intravenous challenge. Eur J Immunol 2014; 44:1069-83.
  52. Pandiyan P, Conti HR, Zheng L et al. CD4+CD25+Foxp3+regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 2011; 34:422-34.
  53. Kumar P, Misra P, Thakur CP et al. T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load. Clin Exp Immunol 2018; 191:318-327.
  54. Bhattacharya P, Ghosh S, Ejazi SA et al. Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+T cells correlates with parasite load in Indian kala-azar patients infected with Leishmania donovani . PLoS Negl Trop Dis. 2016; 10:e0004422.
  55. Guyot-Revol V, Innes JA, Hackforth S et al. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006; 173: 803-10.
  56. Ribeiro-Rodrigues R, Resende Co T, Rojas R et al. A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 2006; 144:25-34.
  57. Chen X, Zhou B, Li M et al. CD4+CD25+FoxP3+regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 2007; 123:50-9.
  58. Li L, Lao SH, Wu CY. Increased frequency of CD4+CD25high Treg cells inhibit BCG-specific induction of IFN-gamma by CD4+ T cells from TB patients. Tuberculosis (Edinb) 2007; 87:526-34.
  59. Ghazalsofala R, Rezaee SA, Rafatpanah H et al. Evaluation of CD4+CD25+ FoxP3+Regulatory T cells and FoxP3 and CTLA-4 gene expression in patients with newly diagnosed tuberculosis in northeast of Iran. Jundishapur J Microbiol 2015; 8:e17726.
  60. Zewdie M, Howe R, Hoff ST et al. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls. Tuberculosis (Edinb) 2016; 100:61-68.
  61. Ahmed A, Adiga V, Nayak S et al. Circulating HLA-DR+CD4+ effector memory T cells resistant to CCR5 and PD-L1 mediated suppression compromise regulatory T cell function in tuberculosis. PLoS Pathog 2018; 14: e1007289.
  62. Ihantola EL, Viisanen T, Gazali AM et al. Effector T Cell resistance to suppression and STAT3 signaling during the development of human type 1 diabetes. J Immunol 2018; 201:1144-153.
  63. Lawson JM, Tremble J, Dayan C et al. Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin Exp Immunol 2008; 154:353-59.
  64. Schneider A, Rieck M, Sanda S et al. The effector T cells of diabetic subjects are resistant to regulation via CD4+FOXP3+ regulatory T cells. J Immunol 2008; 181:7350-355.
  65. Basdeo SA, Moran B, Cluxton D et al. Polyfunctional, Pathogenic CD161+ Th17 lineage cells are resistant to regulatory t cell-mediated suppression in the context of autoimmunity. J Immunol 2015; 195:528-40.
  66. Thorborn GS, Pomeroy L, Ishohanni H et al. Elevated effector cell sensitivity to Treg-cell suppression that is not associated with reduced Th17-cell expression distinguishes HIV+ asymptomatic subjects from progressors. Eur J Immunol. 2012; 42:138-46.
  67. Elahi S, Dinges WL, Lejarcegui N, Laing KJ, Collier AC, Koelle DM, McElrath MJ, Horton H. Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat Med. 2011 Jul 17;17(8):989-95.
  68. Ahmed A, Rakshit S, Vyakarnam A. HIV-TB co-infection: mechanisms that drive reactivation of Mycobacterium tuberculosis in HIV infection. Oral Dis. 2016; 22 Suppl 1:53-60.
  69. Queval CJ, Brosch R, Simeone R. The Macrophage: A disputed fortress in the battle against Mycobacterium tuberculosis . Front Microbiol. 2017; 8:2284.
  70. Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 2012; 12:352-66.
  71. Shafiani S, Dinh C, Ertelt JM, et al. Pathogen-specific Treg cells expand early during Mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. Immunity 2013; 38:1261-70.
  72. Shafiani S, Tucker-Heard G, Kariyone A et al. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 2010; 207:1409-20.
  73. Scott-Browne JP, Shafiani S, Tucker-Heard G et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 2007; 204:2159-69.
  74. Quinn KM, McHugh RS, Rich FJ et al. Inactivation of CD4+CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol 2006; 84:467-74.
  75. Ozeki Y, Sugawara I, Udagawa T et al. Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice. Int Immunol 2010; 22:179-89.
  76. Kursar M, Koch M, Mittrücker HW et al. Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 2007; 178:2661-5.
  77. Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, Shanley C,Basaraba RJ, Orme IM. The hypervirulent Mycobacterium tuberculosis strain HN878induces a potent TH1 response followed by rapid down-regulation. J Immunol. 2007 Jul 1;179(1):522-31.
  78. Cardona P, Marzo-Escartín E, Tapia G et al. Oral administration of heat-killed Mycobacterium manresensis delay progression toward active tuberculosis in C3HeB/FeJ mice. Front Microbiol 2016; 6:1482.
  79. Kapina MA, Rubakova EI, Majorov KB et al. Capacity of lung stroma to educate dendritic cells inhibiting mycobacteria-specific T-cell response depends upon genetic susceptibility to tuberculosis. PLoS One 2013; 8:e72773.
  80. Green AM, Mattila JT, Bigbee CL et al. CD4+regulatory T cells in a cynomolgus macaque model ofMycobacterium tuberculosis infection. J Infect Dis 2010; 202:533-41.
  81. Chen CY, Huang D, Yao S et al. IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB. J Immunol 2012; 188:4278-88.
  82. Semple PL, Binder AB, Davids M et al. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis. Am J Respir Crit Care Med. 2013;187: 1249-58.
  83. Hougardy JM, Verscheure V, Locht C, Mascart F. In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthyMycobacterium tuberculosis -infected humans. Microbes Infect 2007; 9:1325-32.
  84. Roberts T, Beyers N, Aguirre A, Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta, and interleukin-4 mRNA levels. J Infect Dis 2007; 195:870-8.
  85. Davids M, Pooran AS, Pietersen E et al. Regulatory T cells subvert mycobacterial containment in patients failing extensively drug-resistant tuberculosis treatment. Am J Respir Crit Care Med 2018; 198:104-116.
  86. Riou C, Berkowitz N, Goliath R et al. Analysis of the Phenotype of Mycobacterium tuberculosis-specific CD4+ T cells to discriminate latent from active tuberculosis in HIV-uninfected and HIV-infected individuals. Front Immunol 2017; 8:968.
  87. Adekambi T, Ibegbu CC, Cagle S et al. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. J Clin Invest 2015; 125:1827-38.
  88. Venigalla RK, Tretter T, Krienke S. Reduced CD4+CD25- T cell sensitivity to the suppressive function of CD4+CD25highCD127-/lowregulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008; 58:2120-30.
  89. Bhela S, Kempsell C, Manohar M et al. Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127loTregs in multiple sclerosis and in response to IL-6. J Immunol 2015; 194:2180-18
  90. Kawamoto K, Pahuja A, Nettles A et al. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes. Autoimmunity 2012; 45:310-9.
  91. Haufe S, Haug M, Schepp C et al. Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum 2011; 63:3153-62.
  92. Khader SA, Bell GK, Pearl JE et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007; 8:369-77.
  93. Rosain J, Kong XF, Martinez-Barricarte R et al. Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol 2019; 97:360-67.
  94. Caretto D, Katzman SD, Villarino AV et al. Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells. J Immunol 2010; 184: 30-4.
  95. Diller ML, Kudchadkar RR, Delman KA et al. Balancing inflammation: the link between Th17 and regulatory T cells. Mediators Inflamm 2016; 2016:6309219.
  96. Ye ZJ, Zhou Q, Du RH et al. Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion. Clin Vaccine Immunol 2011; 18:1608-15.
  97. Day CL, Abrahams DA, Bunjun R et al. PD-1 Expression onMycobacterium tuberculosis -specific CD4 T cells is associated with bacterial load in human tuberculosis. Front Immunol. 2018; 9:1995.
  98. Amaral EP, Machado de Salles É, Barbosa Bomfim CC et al. Inhibiting adenosine receptor signaling promotes accumulation of effector CD4+ T cells in the lung parenchyma during severe tuberculosis. J Infect Dis 2019; 219: 964-974.
  99. Phillips BL, Mehra S, Ahsan MH et al. LAG3 expression in activeMycobacterium tuberculosis infections. Am J Pathol 2015; 185:820-33.
  100. Gotot J, Gottschalk C, Leopold S et al. Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo. Proc Natl Acad Sci U S A 2012; 109:10468-473.
  101. Patterson SJ, Pesenacker AM, Wang AY et al. T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression. J Clin Invest 2016; 126:1039-351.
  102. Barchet W, Price JD, Cella M et al. Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation. Blood 2006; 107:1497-504.
  103. Kemper C, Chan AC, Green JM et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421:388-92.
  104. Ikeda T, Hirata S, Fukushima S et al. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells. J Immunol 2010; 185:5259-67.
  105. Yi Z, Lin WW, Stunz LL, Bishop GA. The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2. Nat Immunol;15: 866-74.
  106. Truscott SM, Abate G, Price JD et al. CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses. Infect Immun 2010; 78: 5295-306.
  107. Bryce PJ, Oyoshi MK, Kawamoto S et al. TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45. Int Immunol 2006; 18:101-11.
  108. Brunner T, Kasibhatla S, Pinkoski MJ et al. Expression of Fas ligand in activated T cells is regulated by c-Myc. J Biol Chem 2000; 275:9767-72.
  109. Zhang XR, Zhang LY, Devadas S et al. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ 2003; 10:203-10.
  110. Xie J, Wang H. Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis. Arthritis Res Ther 2017; 19:10.
  111. Sun X, Yamada H, Shibata K, et al. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice. J Immunol 2010; 185:2222-30.
  112. Bhaumik S, Basu R. Cellular and molecular dynamics of Th17 differentiation and its developmental plasticity in the intestinal immune response. Front Immunol 2017; 8:254.
  113. Snook JP, Kim C, Williams MA. TCR signal strength controls the differentiation of CD4+ effector and memory T cells. Sci Immunol 2018; 3(25).
  114. Baecher-Allan C, Viglietta V, Hafler DA. Inhibition of human CD4+CD25+/high regulatory T cell function. J Immunol 2002; 169:6210 -7.
  115. Moguche AO, Musvosvi M, Penn-Nicholson A et al. Antigen availability shapes T cell differentiation and function during tuberculosis. Cell Host Microbe 2017; 21:695-706.
  116. Sakai S, Kauffman KD, Sallin MA et al. CD4 T Cell-derived IFN-γ plays a minimal role in control of pulmonary mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease. PLoS Pathog 2016; 12:e1005667.
  117. Lyadova IV, Tsiganov EN, Kapina MA et al. In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs. PLoS One 2010; 5:e10469.
  118. Orme IM, Robinson RT, Cooper AM. The balance between protective and pathogenic immune responses in the TB-infected lung. Nat Immunol 2015 Jan;16(1):57-63.
  119. Gideon HP, Phuah J, Myers AJ et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog 2015; 11: e1004603.
  120. Fletcher HA, Snowden MA, Landry B et al. T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nat Commun 2016; 7:11290.
  121. Pandiyan P, Zheng L, Ishihara S et al. CD4+CD25+Foxp3+regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 2007; 8:1353-62.
  122. Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009; 21:612-8.
  123. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8:523-32.
  124. Gondek DC, Lu LF, Quezada SA, et al. Cutting edge: contact-mediated suppression by CD4+CD25+regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174:1783-86.
  125. Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A 2008; 105:10113-8.
  126. Fallarino F, Grohmann U, Hwang KW et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4:1206-212.
  127. Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T cells. Immunity 2004; 21:503-13.
  128. Deaglio S, Dwyer KM, Gao W et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257-65.
  129. Bopp T, Becker C, Klein M et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007; 204:1303-310.